Pablo Legorreta's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 60,000 LP interests in RPI US Partners 2019, LP done . Disclosure was reported to the exchange on Aug. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2025 | 60,000 | 692,701 | - | - | LP interests in RPI US Partners 2019, LP | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 21,901 | 904,396 | - | 0 | Class A Ordinary Shares | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 03 Jun 2025 | 3,823,996 | 26,441,905 | - | 0 | Class A Ordinary Shares | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 03 Jun 2025 | 3,823,996 | 84,283,430 | - | - | Common Units in ProKidney LP | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 03 Jun 2025 | 3,823,996 | 84,283,430 | - | - | Class B Ordinary Shares | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jun 2025 | 3,823,996 | 22,617,909 | - | 0 | Class A Ordinary Shares | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 13,356,742 | 13,356,742 | - | - | Class E Ordinary Shares | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | Other type of transaction at price $ 0.00 per share. | 16 May 2025 | 857,138 | 857,138 | - | - | Option (Right to Buy) | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | Other type of transaction at price $ 0.00 per share. | 16 May 2025 | 530,348 | 882,495 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2025 | 867,180 | 0 | - | - | Class B Ordinary Shares | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2025 | 867,180 | 0 | - | - | Class B Ordinary Shares | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 288,352 | 352,147 | - | 0 | Class A Ordinary Shares | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 04 Feb 2025 | 532,535 | 23,150,444 | - | 0 | Class A Ordinary Shares | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Feb 2025 | 532,535 | 22,617,909 | - | 0 | Class A Ordinary Shares | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 04 Feb 2025 | 532,535 | 88,107,426 | - | - | Class B Ordinary Shares | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 04 Feb 2025 | 532,535 | 88,107,426 | - | - | Common Units in ProKidney LP | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 13 Jun 2024 | 22,617,909 | 22,617,909 | - | 2.4 | 54,735,340 | Class A Ordinary Shares |
| ProKidney Corp Ordinary | Pablo Legorreta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Legorreta Pablo | Director, Ten Percent Owner | 05 Feb 2024 | 748,952 | 88,639,961 | - | - | Class B Ordinary Shares | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 05 Feb 2024 | 748,952 | 88,639,961 | - | - | Common Units in ProKidney LP | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 05 Feb 2024 | 748,952 | 748,952 | - | 0 | Class A Ordinary Shares | ||
| ProKidney Corp Ordinary | Legorreta Pablo | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 05 Feb 2024 | 748,952 | 0 | - | 0 | Class A Ordinary Shares | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 29.51 per share. | 28 Jun 2023 | 130,000 | 600,000 | - | 29.5 | 3,836,768 | Class A ordinary shares |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 33.00 per share. | 12 Jun 2023 | 45,000 | 425,000 | - | 33.0 | 1,484,946 | Class A ordinary shares |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 32.78 per share. | 12 Jun 2023 | 45,000 | 470,000 | - | 32.8 | 1,474,902 | Class A ordinary shares |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 32.25 per share. | 24 May 2023 | 150,000 | 380,000 | - | 32.2 | 4,837,440 | Class A ordinary shares |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 33.57 per share. | 16 May 2023 | 160,388 | 160,388 | - | 33.6 | 5,383,728 | Class A ordinary shares |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 32.94 per share. | 16 May 2023 | 69,612 | 230,000 | - | 32.9 | 2,293,096 | Class A ordinary shares |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2023 | 10,269 | 0 | - | - | ICAI Interests | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2023 | 10,269 | 692,701 | - | - | ICAI Interests | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 150,640 | 2,700,000 | - | - | LP interests in RPI US Partners 2019, LP | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 94,677,968 | 94,677,968 | - | - | Common Units in ProKidney LP | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 94,677,968 | 94,677,968 | - | - | Class B Ordinary Shares | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 10,500,000 | 10,500,000 | - | - | Earnout Rights | |
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | 07 May 2021 | 1,284,590 | 1,284,590 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | 07 May 2021 | 1,040,410 | 1,040,410 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | 07 May 2021 | 128,459 | 0 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc Ordinary | Pablo Legorreta | Director, CEO, Chairman of the Board | 07 May 2021 | 104,041 | 0 | - | - | LP interests in RPI US Partners 2019, LP |